SELECTIS HEALTH, INC. : Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)

ITEM 3.02 UNREGISTERED SALE OF EQUITY SECURITIES

The following sets forth the information required by Item 701 of Regulation S-B with respect to the unregistered sales of equity securities by Selectis Health, Inc., a Utah corporation (the "Company"):

a. Effective January 6, 2022, in connection with the execution of Financial

    Public Investor Relations Agreement described in Item 8.01 below, the Company
    granted to Gateway Group, Inc., a California corporation an option to purchase
    30,000 shares of common stock of the Company at an exercise price of $6.00 per
    share (the "Option"). The Option has a cashless exercise provision, is fully
    vested as of January 6, 2022, and is exercisable for a period of three years.

b. The Company paid no fees or commissions in connection with the issuance of the

    Option.

c. The sale of the Option was undertaken without registration under the

     Securities Act in reliance upon an exemption from the registration
     requirements of the Securities Act set forth in Sections 4(2) thereunder. We
     did not engage in any public advertising or general solicitation in
     connection with this transaction, and we provided the investor with
     disclosure of all aspects of our business, including providing the investor
     with our reports filed with the Securities and Exchange Commission and other
     financial, business and corporate information.


ITEM 8.01 OTHER EVENTS

On January 6, 2022 the Company executed a Financial Public Investor Relations Agreement (the "Agreement") with Gateway Group, Inc., a California corporation (the "Consultant") to provide non-exclusive consulting services to the Company. The initial term of the Agreement is for twelve (12) months and shall automatically renew every month thereafter unless terminated by either party. As compensation, the Company has agreed to pay to the Consultant a monthly fee of $6,000 and as an additional incentive has granted to the Consultant the Option described above in Item 3.02. A copy of the Agreement is filed herewith as Exhibit 99.1.

ITEM 9.01: FINANCIAL STATEMENTS AND EXHIBITS

  Item   Title
  99.1     Financial Public Investor Relations Agreement
  104    Cover Page Interactive Data File (embedded within the Inline XBRL
         document)

© Edgar Online, source Glimpses